Epilepsy Trial, Recruiting NCT06782074 Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06782074
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 11 and 18 years old
  • People who have been diagnosed with idiopathic generalized epilepsy (a type of epilepsy with no known structural cause in the brain)

Who may not be able to join:

  • People who are younger than 11 years old or older than 18 years old
  • People whose epilepsy is caused by a structural brain abnormality or has an unclear/unknown origin (sometimes called cryptogenic epilepsy)
  • People who have an intellectual disability or a borderline level of cognitive functioning
  • People who do not wish to take part in the study
  • People for whom informed consent has not been obtained (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390382380289

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Registry
ClinicalTrials.gov
Start date
1 June 2023
Est. completion
30 January 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

cognition in patients with IGE throughout standardized tool WISC IV Wechsler Intelligence Scale for Children - Fourth Edition) or WAIS IV Wechsler Adult Intelligence Scale; quality of life in patients with IGE throughout standardized questionnaire; behavioral profile in patients with IGE throughout standardized questionnaire; executive profile of patients with IGE using standardized questionnaire BRIEF 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov